Allergy Therapeutics PLC (AGY)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
10.50p
Buy
12.00p
-0.30p (-2.54%)
Prices updated at 19 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
Prices in GBX
Allergy Therapeutics PLC is a pharmaceutical products company. It develops therapies for allergy based diseases, having its primary market in Germany.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 53.23 |
| 2024 | 53.87 |
| 2023 | 55.79 |
| 2022 | 68.03 |
| 2021 | 73.79 |
| 2020 | 74.17 |
| 2019 | 75.07 |
| 2018 | 75.11 |
| 2017 | 73.85 |
| 2016 | 71.00 |
| 2015 | 71.83 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 10.22 |
| 2024 | 4.41 |
| 2023 | 0.27 |
| 2022 | 0.59 |
| 2021 | 2.59 |
| 2020 | 1.43 |
| 2019 | 0.93 |
| 2018 | 1.19 |
| 2017 | 2.63 |
| 2016 | 2.45 |
| 2015 | 3.40 |
Price/Forward earnings (YTD)
-21.05
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | -59.92 |
| 2024 | -57.29 |
| 2023 | -60.93 |
| 2022 | -17.11 |
| 2021 | 3.31 |
| 2020 | 9.12 |
| 2019 | 5.80 |
| 2018 | -13.92 |
| 2017 | -4.36 |
| 2016 | -24.35 |
| 2015 | 0.27 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | - |
| 2024 | 9.03 |
| 2023 | 16.65 |
| 2022 | 1.93 |
| 2021 | 1.81 |
| 2020 | 1.97 |
| 2019 | 1.82 |
| 2018 | 2.21 |
| 2017 | 1.91 |
| 2016 | 1.87 |
| 2015 | 1.47 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
